iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sets New 1-Year High – Time to Buy?

Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) reached a new 52-week high during trading on Tuesday . The stock traded as high as $102.57 and last traded at $102.57, with a volume of 1060 shares traded. The stock had previously closed at $100.25.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock has a market cap of $1.19 billion, a P/E ratio of 17.75 and a beta of 0.49. The stock’s 50-day moving average is $91.96 and its two-hundred day moving average is $88.89.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Foundations Investment Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth about $54,513,000. BNP Paribas Financial Markets purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $13,108,000. Anfield Capital Management LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at about $10,007,000. JPMorgan Chase & Co. boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 89.4% during the fourth quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock valued at $18,052,000 after buying an additional 100,426 shares during the period. Finally, Cetera Investment Advisers lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 675.4% during the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after acquiring an additional 95,353 shares during the last quarter.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.